Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Our Products
MouseAtlas
iPSC Cell Lines
Knockout Cell Lines
Tumor Cell Lines
Adeno-associated Virus (AAV) Standard Capsid
Featured Catalog
Humanized Mouse Models
HUGO-GT™
HUGO-Ab™
Humanized Target Gene Models
Humanized Immune System Mouse Models
Tool Mice
Cre Mouse Lines
Disease Models
Autoimmune Disease Models
Ophthalmic Disease Models
Immunodeficient Mouse Models
Metabolic Disease Models
Neurological Disease Models
Oncology & Immuno-oncology Models
Services
Model Generation Techniques
Turboknockoutᵀᴹ Gene Targeting
Cre-ESCs Gene Editing
Targeted Gene Editing
Genetically Engineered Animals
Knockin Mice
Knockin Rats
Knockout Mice
Knockout Rats
Transgenic Mice
Transgenic Rats
Transgenic Model Generation
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Adenovirus Packaging
Lentivirus Packaging
Custom Cell Line Services
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Overexpression Cell Lines
Point Mutation Cell Lines
Breeding & Supporting Services
BAC Modification
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
Drug Discovery and Development
Antibody Discovery Platform
HUGO-Ab™
HUGO-Mab™
HUGO-Light™
HUGO-Nano™
HUGO-Ab-eKO™
Therapeutic Area
Neurology
Alzheimer's Disease (AD)
Parkinson's Disease (PD)
Huntington's Disease (HD)
Blood Brain Barrier (BBB)
Metabolic & Cardiovascular
Obesity
Ophthalmology
Glaucoma
Age-Related Macular Degeneration (AMD)
Oncology
PBMC Humanized Mouse Model
Human Immune System (HIS) Mouse Model
Immunology & Inflammation
Asthma
Innovative Drug R&D
Therapeutic Antibody Drugs
Monoclonal Antibodies (mAb)
Bispecific Antibodies (BsAb)
ADC/AOC
AI-Powered AAV Discovery
Cell Immunotherapy
Gene Therapy
Oligonucleotide Therapy
Fully Human Antibody Library
Neurology Antibodies
Metabolic & Cardiovascular Antibodies
Ophthalmology Antibodies
Oncology Antibodies
Immunology & Inflammation Antibodies
Resources
News
Blogs & Insight
Promotion
Events & Webinars
Databases
AbSeek
Rare Disease Data Center
Cell iGeneEditor™ System
Citations
Resource Vault
OriCell
About Us
Animal Health & Welfare
Corporate Overview
Facility Overview
Our Team
Our Partners
Careers
Health Reports
Contact Us
Login
HomeMouseAtlas
C57BL/6JCya-Hmcn1em1/Cya
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
+
-
Organization
Job Role
Country
Catalog Type
Product Name
Main Area of Research
How did you hear about us?
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.

C57BL/6JCya-Hmcn1em1/Cya

Common Name
Hmcn1-KO
Product ID
S-KO-18258
Backgroud
C57BL/6JCya
Strain ID
KOCMP-545370-Hmcn1-B6J-VB
Status
Research and Development
When using this mouse strain in a publication, please cite “Hmcn1-KO Mouse (Catalog S-KO-18258) were purchased from Cyagen.”
KO Models
Product Type
Age
Genotype
Sex
Quantity
The standard delivery applies for a guaranteed minimum of three heterozygous carriers. Breeding services for homozygous carriers and/or specified sex are available.
+
KO Models
Basic Information
Strain Name
Hmcn1-KO
Strain ID
KOCMP-545370-Hmcn1-B6J-VB
Gene Name
Hmcn1
Product ID
S-KO-18258
Gene Alias
Gm201, FIBL-6, EG545370
Background
C57BL/6JCya
Gene Full Name
hemicentin 1
Modification
Conventional knockout
NCBI ID
545370 (Mouse)
Phenotype
MGI:2685047
Chromosome
Chr 1 (Mouse)
Application
--
Datasheet
Click here to download >>
More
Rare Disease Data Center >>
Strain Description
Ensembl Transcript ID
ENSMUST00000074783
NCBI Transcript ID
NM_001024720
Target Region
Exon 2~4
Size of Effective Region
~18.4 kb
Overview of Gene Research
Hmcn1, which codes for hemicentin-1, is an extracellular matrix protein. It belongs to the fibulin family and plays pivotal roles in development and tissue homeostasis. Hmcn1 is involved in maintaining basement membrane integrity and interacts with proteins like nidogen-2 and laminins [7]. It also contributes to processes related to cell-matrix interactions and may be involved in various signaling pathways.

In epidermolysis bullosa simplex (EBS), deleterious variants in Hmcn1 co-segregate with a more severe phenotype in individuals with EBS caused by KRT14 mutations. Hemicentin-1 binds K14, and its deficiency leads to subepidermal blisters and reduced keratin intermediate filament formation, indicating its role in basement membrane zone (BMZ) stability [1]. In clear cell renal cell carcinoma (ccRCC), Hmcn1 mutation is associated with tumor mutation burden, clinical prognosis, and may regulate metabolism and the immune microenvironment [2]. In ovarian carcinoma, SRPX and Hmcn1 in cancer-associated fibroblasts (CAFs) are upregulated, and their silencing suppresses OC cell invasion via the RhoA signaling pathway [3]. In breast cancer, the variant allele frequency (VAF) of Hmcn1 correlates with prognosis and lymph node status, suggesting it as a potential metastatic factor [4]. In tooth root formation, Hmcn1 promotes mesenchymal cell differentiation, influencing dentinogenesis and pulp cell migration [5]. In glomerular diseases, increased Hmcn1 expression is associated with podocyte dysfunction and may serve as a marker for early glomerular damage [6].

In conclusion, Hmcn1 is crucial for maintaining tissue integrity and function in various biological processes. Its role in diseases such as EBS, ccRCC, ovarian carcinoma, breast cancer, and in dental and kidney-related conditions has been revealed through genetic and functional studies. These findings from different research models contribute to our understanding of the biological functions of Hmcn1 and its implications in disease mechanisms.

References:
1. Bergson, Shir, Sarig, Ofer, Giladi, Moshe, Rubinstein, Rotem, Sprecher, Eli. 2025. HMCN1 variants aggravate epidermolysis bullosa simplex phenotype. In The Journal of experimental medicine, 222, . doi:10.1084/jem.20240827. https://pubmed.ncbi.nlm.nih.gov/39976600/
2. Gong, Ziqi, Wu, Xiaowen, Guo, Qian, Zhang, Fenghao, Kong, Yan. 2022. Comprehensive Analysis of HMCN1 Somatic Mutation in Clear Cell Renal Cell Carcinoma. In Genes, 13, . doi:10.3390/genes13071282. https://pubmed.ncbi.nlm.nih.gov/35886066/
3. Liu, Chao Lien, Pan, Hung Wei, Torng, Pao Ling, Fan, Ming Huei, Mao, Tsui Lien. 2019. SRPX and HMCN1 regulate cancer‑associated fibroblasts to promote the invasiveness of ovarian carcinoma. In Oncology reports, 42, 2706-2715. doi:10.3892/or.2019.7379. https://pubmed.ncbi.nlm.nih.gov/31638245/
4. Kikutake, Chie, Yoshihara, Minako, Sato, Tetsuya, Saito, Daisuke, Suyama, Mikita. 2018. Intratumor heterogeneity of HMCN1 mutant alleles associated with poor prognosis in patients with breast cancer. In Oncotarget, 9, 33337-33347. doi:10.18632/oncotarget.26071. https://pubmed.ncbi.nlm.nih.gov/30279964/
5. Cui, Yujia, Li, Chuwen, Wang, Hanyang, Zhang, Hai, Sun, Jianxun. 2024. Hemicentin-1 is an essential extracellular matrix component during tooth root formation by promoting mesenchymal cells differentiation. In Frontiers in cell and developmental biology, 12, 1435241. doi:10.3389/fcell.2024.1435241. https://pubmed.ncbi.nlm.nih.gov/39050894/
6. Toffoli, Barbara, Zennaro, Cristina, Winkler, Carine, Gilardi, Federica, Desvergne, Béatrice. 2018. Hemicentin 1 influences podocyte dynamic changes in glomerular diseases. In American journal of physiology. Renal physiology, 314, F1154-F1165. doi:10.1152/ajprenal.00198.2017. https://pubmed.ncbi.nlm.nih.gov/29488390/
7. Zhang, Jin-Li, Richetti, Stefania, Ramezani, Thomas, Sengle, Gerhard, Hammerschmidt, Matthias. 2022. Vertebrate extracellular matrix protein hemicentin-1 interacts physically and genetically with basement membrane protein nidogen-2. In Matrix biology : journal of the International Society for Matrix Biology, 112, 132-154. doi:10.1016/j.matbio.2022.08.009. https://pubmed.ncbi.nlm.nih.gov/36007682/
Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Contact Us
Connect with our experts for your custom animal model needs. Please fill out the form below to start a conversation or request a quote.
Inquiry Details
Main Area of Research
Service(s) of Interest
Gene of Interest
Project Details
How did you hear about us?
Contact Information
Full Name
Email
Phone Number
+
-
Organization
Job Role
Country
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our  Privacy Policy  for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0336
Email:
inquiry@cyagen.com
Services
HUGO-GT™HUGO-Ab™iPSC Cell LinesAdeno-associated Virus (AAV) Standard Capsid
Drug R&D
NeurologyMetabolicOphthalmologyOncology
About Us
Animal Health & WelfareCorporate OverviewOur TeamHealth Reports
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Global Antibody Drug Industry Development BlueBook (Frost & Sullivan)
Key Insights
The industry is undergoing a rapid transformation driven by next-generation modalities, globalized markets, and upstream technological innovations.
  • Market Structural Shift: Monoclonal antibodies drive steady growth, but ADCs and bispecifics are rapidly accelerating, reshaping the market with higher-value innovations.
  • Chinese Market Globalization: China is actively expanding globally, evidenced by a surge in high-value cross-border license-out deals.
  • Technology-Driven Efficiency: Advanced discovery engines—exemplified by Cyagen's HUGO-Ab platform and AI algorithms—are streamlining candidate screening, optimizing molecular design, and localizing the upstream supply chain.
  • Oncology-Focused Innovation: R&D pipelines remain heavily concentrated on high-incidence malignancies like non-small cell lung cancer, utilizing complex modalities to combat clinical resistance.
Now Available for Download
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest
Main Area of Research